Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Haemonetics Corp. buy BTIG Research

Start price
€66.50
10.09.24 / 50%
Target price
€101.52
10.09.25
Performance (%)
5.26%
Price
€70.00
03.10.24
Summary
This prediction is currently active. The BUY prediction by BTIG_Research shows slight gains of 5.26%. This prediction currently runs until 10.09.25. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this prediction
Performance without dividends (%)
Name 1w
Haemonetics Corp. -1.408%
iShares Core DAX® -1.114%
iShares Nasdaq 100 1.816%
iShares Nikkei 225® 2.113%
iShares S&P 500 2.038%

Comments by BTIG_Research for this prediction

In the thread Haemonetics Corp. diskutieren
Prediction Buy
Perf. (%) 5.26%
Target price 101.517
Change
Ends at 10.09.25

Haemonetics Co. (NYSE: HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat